Seed financing announcement for new ICR and Oxford spinout company Kodiform Therapeutics 11 Jun 2024 Kodiform Therapeutics, a new joint spin-out company from The Institute of Cancer Research, London, and the University of Oxford, has received a major seed funding investment from venture creation firm Oxford Science Enterprises. Find out more Show/Hide
ICR and Merck renew strategic alliance in discovery and development of innovative new small-molecule cancer drugs 22 Sep 2023 The Institute of Cancer Research, London, and science and technology company Merck have renewed their strategic alliance in the discovery and development of new cancer drugs. Find out more Show/Hide
Meet our scientists at upcoming industry collaboration events 22 Feb 2023 Upcoming events will give industry experts the chance to hear from some of our leading researchers about opportunities to work with them. Find out more Show/Hide